menu

CME: COPD: Applying New Guidelines to Optimizing Evaluation and Treatment

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

COPD: Applying New Guidelines to Optimizing Evaluation and Treatment

COPD: Applying New Guidelines to Optimizing Evaluation and Treatment
RestartResume
Join this panel of experts as they discuss patient cases to interpret recent guidelines for COPD diagnosis and management.

Available credits: 0.25

Time to complete: 15 Minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    The costs related to COPD care continue to grow, and are projected to be $49 billion annually by 2020, with the majority of costs due to hospital care. Unfortunately, many patients with COPD are still undiagnosed, undermanaged, and proceed down the path of irreversible lung damages.

    This case review will interpret the most recently released COPD diagnosis and management guidelines to optimally individualize therapy.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:

    Jennifer Caudle, DO
    Family Medicine Physician and Assistant Professor
    Department of Family Medicine
    Rowan University-School of Osteopathic Medicine
    Stratford, NJ

    Dr. Caudle has nothing to disclose. 

    Faculty: 

    Nicola A. Hanania, MD, MS
    Associate Professor of Medicine
    Pulmonary and Critical Care Medicine
    Director, Asthma Clinical Research Center
    Baylor College of Medicine
    Houston, TX 

    Dr. Hanania receives consulting fees from AstraZeneca, GlaxoSmithKline, Novartis, and Sanofi/Regeneron and has contracted research with AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline.

    Frank C. Sciurba, MD, FCCP
    Visiting Professor of Medicine and Education
    Director, Emphysema/COPD Research Center
    Division of Pulmonary and Critical Care Medicine
    University of Pittsburgh
    Pittsburgh, PA

    Dr. Sciurba has nothing to disclose.

    Reviewers/Planners/Authors:

    • Carole Drexel, PhD has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Nick Lombardi has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Apply current 2017 guideline-recommended strategies for confirming a diagnosis of COPD and assessing risk to guide appropriate treatment selection.
    • Formulate treatment plans based on consideration of risk classification, patient comorbidities, and presentation.
    • Explain the rational for new and emerging therapies, and inhaler devices for COPD.
  • Target Audience

    This activity is designed to meet the educational needs of pulmonologists and other clinicians treating COPD patients.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Prova Education designs educational activities based on evidence-based medicine, needs and gaps analyses, learner feedback, and more. Its mission is to serve as an innovative and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

  • Commercial Support

    This activity is supported by an independent educational grant from Sunovion Pharmaceuticals.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.